相关实验视频
Updated: Jul 7, 2025

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
35.8K
通过ERK通路激活,SLC35A2表达驱动乳腺癌的进展
Xiaochen Yang1, Yukai Tao2, Yan Xu1
1Department of Thyroid and Breast Surgery, Affiliated Kunshan Hospital of Jiangsu University, China.
The FEBS journal
|December 25, 2023
概括
改变的糖化对乳腺癌有影响. 溶解物载体家族35成员A2 (SLC35A2) 基因通过激活ERK信号来促进乳腺侵入性癌 (BRCA) 的进展,提供潜在的治疗标.
科学领域:
- 分子瘤学分子瘤学
- 癌症 糖基化 糖基化 糖基化
- 信号传输 信号传输
背景情况:
- 异常的糖化化与乳腺瘤的发展和进展有关.
- 在乳腺侵入性癌症 (BRCA) 中,UDP-银糖转运基因SLC35A2的确切作用尚不清楚.
- 了解SLC35A2的功能对于确定BRCA中的新疗法策略至关重要.
研究的目的:
- 阐明SLC35A2在乳腺侵入性癌 (BRCA) 的功能和机制.
- 研究BRCA中SLC35A2的上游调控途径.
- 评估SLC35A2表达和瘤免疫微环境之间的相关性.
主要方法:
- 使用公共数据库分析SLC35A2表达和预后意义.
- 定量PCR和双化酶试验验证ncRNA调节的有效性.
- 在体外 (细胞系) 和体内 (异种移植模型) 实验中评估增殖,运动,细胞周期,细胞亡和瘤生长.
- 生物信息分析和免疫组织化学用于免疫透评估.
主要成果:
- 在BRCA中,SLC35A2的表达被上调,并与预后不佳有关.
- AC074117.1/hsa-let-7b-5p轴被确定为SLC35A2.2.的主要上游调节器.
- 通过ERK信号激活,SLC35A2促进BRCA细胞的增殖,运动,并通过ERK信号激活抑制细胞亡.
- SLC35A2表达与Th2细胞,调节性T细胞和免疫检查点正相关.
结论:
- 通过SLC35A2的AC074117.1/hsa-let-7b-5p轴介导的上调,通过ERK信号驱动BRCA的进展.
- 在BRCA中,SLC35A2充当瘤基因,影响瘤生长和免疫微环境.
- 准SLC35A2为乳腺侵入性癌症提供了一个有前途的治疗途径.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K

